| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.31B | 52.37B | 50.83B | 51.84B | 42.94B | 42.53B |
| Gross Profit | 8.75B | 9.80B | 8.41B | 6.99B | 6.92B | 6.65B |
| EBITDA | 4.51B | 5.56B | 4.57B | 3.41B | 3.45B | 3.50B |
| Net Income | 2.62B | 3.45B | 2.59B | 1.90B | 1.66B | 1.87B |
Balance Sheet | ||||||
| Total Assets | 45.02B | 47.20B | 46.07B | 46.33B | 37.66B | 35.21B |
| Cash, Cash Equivalents and Short-Term Investments | 9.81B | 10.60B | 10.85B | 3.29B | 6.17B | 5.12B |
| Total Debt | 1.59B | 1.05B | 1.43B | 5.09B | 1.36B | 1.19B |
| Total Liabilities | 20.43B | 19.20B | 21.08B | 23.70B | 16.70B | 15.85B |
| Stockholders Equity | 24.58B | 27.98B | 24.98B | 22.63B | 20.97B | 19.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.22B | 11.57B | -5.87B | 1.21B | 1.84B |
| Operating Cash Flow | 0.00 | 1.94B | 12.93B | -4.74B | 1.83B | 3.05B |
| Investing Cash Flow | 0.00 | -875.48M | -1.28B | -1.08B | -647.69M | -1.35B |
| Financing Cash Flow | 0.00 | -1.35B | -4.17B | 2.89B | -196.40M | -1.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥22.74B | 9.25 | ― | 2.37% | 2.65% | 7.45% | |
74 Outperform | ¥22.10B | 8.04 | ― | 2.97% | -9.99% | 58.24% | |
73 Outperform | ¥77.37B | 11.38 | ― | 1.25% | 4.37% | 6.30% | |
72 Outperform | ¥24.64B | 6.83 | ― | 3.44% | 3.02% | 32.92% | |
70 Outperform | ¥7.15B | 15.23 | ― | 3.77% | 10.82% | 30.60% | |
70 Outperform | ¥8.13B | 14.91 | ― | 2.03% | 26.86% | 0.06% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |